1. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation. Issue 11 (November 2020) Authors: Prat, Aleix; Guarneri, Valentina; Paré, Laia; Griguolo, Gaia; Pascual, Tomás; Dieci, Maria V; Chic, Núria; González-Farré, Blanca; Frassoldati, Antonio; Sanfeliu, Esther; Cejalvo, Juan M; Muñoz, Montserrat; Bisagni, Giancarlo; Brasó-Maristany, Fara; Urso, Loredana; Vidal, Maria; Brandes, Alba A; ... Journal: Lancet oncology Issue: Volume 21:Issue 11(2020) Page Start: 1455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial. Issue 1 (February 2023) Authors: Conte, Benedetta; Montemurro, Filippo; Levaggi, Alessia; Blondeaux, Eva; Molinelli, Chiara; Cardinali, Barbara; Poggio, Francesca; Buzzatti, Giulia; Bighin, Claudia; Lambertini, Matteo; Del Mastro, Lucia Journal: Tumori Issue: Volume 109:Issue 1(2023) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dose‐dense adjuvant chemotherapy in HER2‐positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. Issue 1 (4th December 2019) Authors: Lambertini, Matteo; Poggio, Francesca; Bruzzone, Marco; Conte, Benedetta; Bighin, Claudia; de Azambuja, Evandro; Giuliano, Mario; De Laurentiis, Michele; Cognetti, Francesco; Fabi, Alessandra; Bisagni, Giancarlo; Durando, Antonio; Turletti, Anna; Urracci, Ylenia; Garrone, Ornella; Puglisi, Fabio;... Journal: International journal of cancer Issue: Volume 147:Issue 1(2020) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial. (September 2020) Authors: Conte, Benedetta; Bruzzone, Marco; Lambertini, Matteo; Poggio, Francesca; Bighin, Claudia; Blondeaux, Eva; De Laurentiis, Michelino; Valle, Enrichetta; Cognetti, Francesco; Nisticò, Cecilia; De Placido, Sabino; Garrone, Ornella; Gamucci, Teresa; Montemurro, Filippo; Puglisi, Fabio; Cardinali, Bar... Journal: European journal of cancer Issue: Volume 136(2020) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis. (March 2020) Authors: Schettini, Francesco; Pascual, Tomás; Conte, Benedetta; Chic, Nuria; Brasó-Maristany, Fara; Galván, Patricia; Martínez, Olga; Adamo, Barbara; Vidal, Maria; Muñoz, Montserrat; Fernández-Martinez, Aranzazu; Rognoni, Carla; Griguolo, Gaia; Guarneri, Valentina; Conte, Pier Franco; Locci, Mariavittori... Journal: Cancer treatment reviews Issue: Volume 84(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. (28th December 2022) Authors: Brasó-Maristany, Fara; Griguolo, Gaia; Chic, Nuria; Pascual, Tomás; Paré, Laia; Maues, Julia; Galván, Patricia; Dieci, Maria Vittoria; Miglietta, Federica; Giarratano, Tommaso; Martínez-Sáez, Olga; Marín-Aguilera, Mercedes; Schettini, Francesco; Conte, Benedetta; Angelats, Laura; Vidal, Maria; Ad... Journal: Journal of the National Cancer Institute Issue: Volume 115:Number 3(2023) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak. (5th July 2020) Authors: Tagliamento, Marco; Spagnolo, Francesco; Poggio, Francesca; Soldato, Davide; Conte, Benedetta; Ruelle, Tommaso; Barisione, Emanuela; De Maria, Andrea; Del Mastro, Lucia; Di Maio, Massimo; Lambertini, Matteo Journal: European journal of clinical investigation Issue: Volume 50:Number 9(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancer. (2nd September 2017) Authors: Conte, Benedetta; Poggio, Francesca; Del Mastro, Lucia Journal: Expert opinion on pharmacotherapy Issue: Volume 18:Number 13(2017) Page Start: 1357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives. (January 2023) Authors: Sirico, Marianna; Virga, Alessandra; Conte, Benedetta; Urbini, Milena; Ulivi, Paola; Gianni, Caterina; Merloni, Filippo; Palleschi, Michela; Gasperoni, Marco; Curcio, Annalisa; Saha, Debjani; Buono, Giuseppe; Muñoz, Montserrat; De Giorgi, Ugo; Schettini, Francesco Journal: Critical reviews in oncology/hematology Issue: Volume 181(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review. (July 2019) Authors: Poggio, Francesca; Lambertini, Matteo; Bighin, Claudia; Conte, Benedetta; Blondeaux, Eva; D'Alonzo, Alessia; Dellepiane, Chiara; Buzzatti, Giulia; Molinelli, Chiara; Boccardo, Francesco; Del Mastro, Lucia Journal: Clinical medicine insights Issue: Volume 13(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗